The Python-based information stealer SolyxImmortal uses legitimate APIs and libraries for stealthy data gathering and ...

I tried four vibe-coding tools, including Cursor and Replit, with no coding background. Here's what worked (and what didn't).

This approach allows developers to create applications through natural language conversations rather than traditional ...

Replit’s new feature generates iOS apps from text prompts, integrates monetization, and streamlines App Store publishing - ...

Over the past couple of days, several Discord users on Windows 11/10 have been complaining about an error where the social platform is stuck in an update loop with no ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

If you are following Replimune Group (REPL) right now, you’re not alone. The company’s recent announcement about completing a Type A meeting with the FDA on its lead drug candidate, RP1, has put it ...

We recently published 10 Stocks Losing Big Amid Market Boom. Replimune Group, Inc. (NASDAQ:REPL) is one of the worst performers on Thursday. Replimune extended losses to a second consecutive day on ...

The fate of a once-promising cancer treatment now looks uncertain at best. The meeting was conducted with U.S. Food and Drug Administration (FDA) officials, and it took place on Tuesday. The subject ...

Shares of Replimune (NASDAQ:REPL) plunged ~38% in the premarket on Monday after Stat News reported that the FDA’s top regulator of cancer drugs intervened during the review of the company’s lead asset ...